Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:CARM - FR0010828137 - REIT

16.7 EUR
-0.08 (-0.48%)
Last: 12/5/2025, 5:29:21 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CARM. CARM was compared to 42 industry peers in the Diversified REITs industry. While CARM has a great profitability rating, there are some minor concerns on its financial health. CARM may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CARM had positive earnings in the past year.
In the past year CARM had a positive cash flow from operations.
Of the past 5 years CARM 4 years were profitable.
Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

CARM has a Return On Assets of 5.24%. This is amongst the best in the industry. CARM outperforms 90.48% of its industry peers.
The Return On Equity of CARM (10.53%) is better than 92.86% of its industry peers.
CARM has a better Return On Invested Capital (4.91%) than 85.71% of its industry peers.
CARM had an Average Return On Invested Capital over the past 3 years of 3.52%. This is in line with the industry average of 3.53%.
The last Return On Invested Capital (4.91%) for CARM is above the 3 year average (3.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROIC 4.91%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 64.32%, CARM is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
CARM's Profit Margin has improved in the last couple of years.
CARM has a Operating Margin of 87.92%. This is amongst the best in the industry. CARM outperforms 92.86% of its industry peers.
In the last couple of years the Operating Margin of CARM has grown nicely.
CARM has a Gross Margin (72.59%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CARM has remained more or less at the same level.
Industry RankSector Rank
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

4

2. Health

2.1 Basic Checks

CARM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CARM has been reduced compared to 1 year ago.
The number of shares outstanding for CARM has been increased compared to 5 years ago.
CARM has a better debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.96, we must say that CARM is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 0.96, CARM is doing good in the industry, outperforming 61.90% of the companies in the same industry.
The Debt to FCF ratio of CARM is 8.32, which is on the high side as it means it would take CARM, 8.32 years of fcf income to pay off all of its debts.
CARM has a better Debt to FCF ratio (8.32) than 95.24% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that CARM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, CARM is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Altman-Z 0.96
ROIC/WACC0.96
WACC5.1%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 0.74. This is a bad value and indicates that CARM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Current ratio value of 0.74, CARM is doing good in the industry, outperforming 64.29% of the companies in the same industry.
A Quick Ratio of 0.74 indicates that CARM may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.74, CARM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 572.32% over the past year.
CARM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.86% yearly.
Looking at the last year, CARM shows a quite strong growth in Revenue. The Revenue has grown by 17.64% in the last year.
The Revenue has been growing slightly by 2.93% on average over the past years.
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%

3.2 Future

The Earnings Per Share is expected to grow by 5.14% on average over the next years.
The Revenue is expected to grow by 4.22% on average over the next years.
EPS Next Y8.26%
EPS Next 2Y6.05%
EPS Next 3Y5.14%
EPS Next 5YN/A
Revenue Next Year11.68%
Revenue Next 2Y7.07%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.71, which indicates a rather cheap valuation of CARM.
97.62% of the companies in the same industry are more expensive than CARM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CARM to the average of the S&P500 Index (26.41), we can say CARM is valued rather cheaply.
The Price/Forward Earnings ratio is 8.81, which indicates a very decent valuation of CARM.
Based on the Price/Forward Earnings ratio, CARM is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
CARM is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.40, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.71
Fwd PE 8.81
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CARM is valued cheaper than 95.24% of the companies in the same industry.
85.71% of the companies in the same industry are more expensive than CARM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.01
EV/EBITDA 10.38
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CARM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.81
PEG (5Y)0.29
EPS Next 2Y6.05%
EPS Next 3Y5.14%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.33%, CARM is a good candidate for dividend investing.
CARM's Dividend Yield is rather good when compared to the industry average which is at 5.80. CARM pays more dividend than 83.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.33%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CARM pays out 50.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50.04%
EPS Next 2Y6.05%
EPS Next 3Y5.14%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (12/5/2025, 5:29:21 PM)

16.7

-0.08 (-0.48%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-23 2025-10-23
Earnings (Next)01-07 2026-01-07/amc
Inst Owners34.14%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.35B
Revenue(TTM)547.98M
Net Income(TTM)352.45M
Analysts78.57
Price Target21.08 (26.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.33%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP50.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.48%
PT rev (3m)2.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.14%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 6.71
Fwd PE 8.81
P/S 4.3
P/FCF 7.01
P/OCF 6.95
P/B 0.7
P/tB 0.7
EV/EBITDA 10.38
EPS(TTM)2.49
EY14.91%
EPS(NY)1.89
Fwd EY11.35%
FCF(TTM)2.38
FCFY14.26%
OCF(TTM)2.4
OCFY14.38%
SpS3.89
BVpS23.74
TBVpS23.73
PEG (NY)0.81
PEG (5Y)0.29
Graham Number36.47
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROCE 7.65%
ROIC 4.91%
ROICexc 5%
ROICexgc 5%
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
FCFM 61.25%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexgc growth 3Y20.72%
ROICexgc growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Debt/EBITDA 5.3
Cap/Depr 68.54%
Cap/Sales 0.52%
Interest Coverage 3.91
Cash Conversion 69.65%
Profit Quality 95.22%
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 0.96
F-Score5
WACC5.1%
ROIC/WACC0.96
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
EPS Next Y8.26%
EPS Next 2Y6.05%
EPS Next 3Y5.14%
EPS Next 5YN/A
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%
Revenue Next Year11.68%
Revenue Next 2Y7.07%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y69.71%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year7.42%
EBIT Next 3Y4.73%
EBIT Next 5Y2.86%
FCF growth 1Y20.89%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y20.76%
OCF growth 3Y4.74%
OCF growth 5Y1.02%

CARMILA / CARM.PA FAQ

Can you provide the ChartMill fundamental rating for CARMILA?

ChartMill assigns a fundamental rating of 6 / 10 to CARM.PA.


Can you provide the valuation status for CARMILA?

ChartMill assigns a valuation rating of 9 / 10 to CARMILA (CARM.PA). This can be considered as Undervalued.


Can you provide the profitability details for CARMILA?

CARMILA (CARM.PA) has a profitability rating of 8 / 10.


What are the PE and PB ratios of CARMILA (CARM.PA) stock?

The Price/Earnings (PE) ratio for CARMILA (CARM.PA) is 6.71 and the Price/Book (PB) ratio is 0.7.


What is the expected EPS growth for CARMILA (CARM.PA) stock?

The Earnings per Share (EPS) of CARMILA (CARM.PA) is expected to grow by 8.26% in the next year.